Simulations Plus to Present at Oppenheimer Annual Healthcare Conference

Rhea-AI Summary

Simulations Plus (Nasdaq: SLP) announced its participation in Oppenheimer’s 32nd Annual Healthcare Conference, occurring virtually on March 15-16, 2022. CEO Shawn O’Connor will present on March 15 at 4:00 p.m. ET and will also host one-on-one meetings. Interested parties can access the live event or request meetings via their Oppenheimer representatives. The presentation slides will be available afterwards on the company’s Investors page.

Simulations Plus, serving clients for 25 years, specializes in modeling and simulation software for pharmaceutical development and research.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at Oppenheimer’s 32nd Annual Healthcare Conference taking place virtually from March 15-16, 2022.

Shawn O’Connor, chief executive officer, will present on Tuesday, March 15, 2022, at 4:00 p.m. ET. In addition, Mr. O’Connor will be available to host one-on-one meetings throughout the day. To listen to the live event or request a one-on-one meeting, please contact your Oppenheimer representative. The Company’s slide presentation will be available on the Investors page of the Simulations Plus website following the presentation.

For more information about the Oppenheimer Annual Healthcare Conference, or to register to attend, please visit the conference website or contact Brian Siegel from Hayden IR at brian@haydenir.com.

About Simulations Plus

Serving clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn.

Environmental, Social, and Governance (ESG)

We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220308005001/en/

Simulations Plus Investor Relations

Ms. Renee Bouche

661-723-7723

renee.bouche@simulations-plus.com

Hayden IR

Mr. Brian Siegel

346-396-8696

brian@haydenir.com

Source: Simulations Plus, Inc.

FAQ

When is Simulations Plus presenting at the Oppenheimer Healthcare Conference?

Simulations Plus will present on March 15, 2022, at 4:00 p.m. ET.

Who is presenting for Simulations Plus at the Oppenheimer Conference?

CEO Shawn O’Connor will present at the Oppenheimer Healthcare Conference.

How can I listen to the Simulations Plus presentation at the conference?

You can listen to the presentation live by contacting your Oppenheimer representative.

Where can I find the presentation slides from Simulations Plus?

The presentation slides will be available on the Simulations Plus Investors page after the event.

What services does Simulations Plus provide?

Simulations Plus provides modeling and simulation software for drug discovery, development, and regulatory submissions.